Tryton Medical's side branch stent wins CE Mark approval in the European Union for treating left main coronary artery disease.
Tryton Medical said it won CE Mark approval in the European Union for its side-branch stent to treat left main coronary artery disease.
Durham, N.C.-based Tryton already has European clearance for the side branch stent, but only for treating bifurcated large-vessel lesions. The new approval makes the device the only stent cleared in Europe for the left main indication, according to a press release.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/NGW0ms
Cap comentari:
Publica un comentari a l'entrada